Skip to main content
RCKT filings

Corporate insider profile

Gaurav Shah Filing Activity

Latest reported as CEO of ROCKET PHARMACEUTICALS, INC. (RCKT).

Purchase filings
0
Reported companies
1
Net open-market value
-$188,938.72
Latest transaction
May 21, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 21, 2026ROCKET PHARMACEUTICALS, INC. (RCKT)CEOSale55,684$3.09$171,841
May 19, 2026ROCKET PHARMACEUTICALS, INC. (RCKT)CEOSale2,409$3.01$7,261
May 13, 2026ROCKET PHARMACEUTICALS, INC. (RCKT)CEOSale2,728$3.61$9,837